InterventionsHuman trial

Efficacy and Safety of Semaglutide According to Frailty Status in the SELECT Trial

AHA Scientific Sessions 2025 Abstract

The paper

Ostrominski J, Plutzky J, Scirica B et al.

AHA Scientific Sessions 2025 Abstract · 3 Nov 2025

Presented at AHA Scientific Sessions 2025 · Abstract 4365716

doi.org/10.1161/circ.152.suppl_3.4365716

Semaglutide may protect kidneys by reducing vascular resistance
Nature Medicine · 4 Oct 2026
Metabolic signature links frailty to coronary artery disease
The Journal of Nutrition, Health & Aging · 4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026
Multidisciplinary care reduces frailty in older cardiac patients
Nature Communications · 4 Oct 2026